Hold JPM at 3% weight through Q3 catalyst; reject accumulation (4 resistance layers) and underweight (franchise floor held); pre-committed earnings scenarios with active triggers
Hold JPM at ~3% portfolio weight through Q3 2026 earnings catalyst; intellectually honest synthesis captures franchise quality (17.8% ROE, $5T balance sheet, ~5% capital return yield, 14.2x P/E) supporting ownership and broken momentum with binary catalyst arguing against fresh capital. Reject Aggressive Analyst (1.6:1 R/R asymmetric to downside, four stacked resistance layers, no-cut probability fully priced, brutal comp math with Q2 $7.70 EPS flattered by ~$4.39B pretax special items normalizing to $6.85-7.00) and reject Conservative Analyst (9/28 linear trim captured only -0.3% alpha, franchise floor held exactly as predicted, put-spread overlay bleeds alpha in modest relative underperformance setups). Active architecture (pre-committed Q3 scenarios, closing-basis stops with ATR buffer, -2% relative-to-SPY clause, 3-week mandatory reassessment) converts passive drift into executable discipline.
| Position | Action |
|---|---|
| JPM closes above $351.82 on above-average volume with RSI >55 and MACD histogram contracting | Add 25% to position on next pullback to 10 EMA with confirmation |
| JPM rallies to $336-340 (10 EMA confluence) | Trim into strength IF overweight |
| JPM rallies to $346-349 (Bollinger mid/50 SMA retest) | Trim into strength IF overweight |
| Close below $320.27 on above-average volume with 2-3 session hold | Trim trigger with ATR buffer (closing-basis, not wick stops) |
| Print ≥$6.50 + NII guide reaffirmed + stable deposit commentary (Q3 Bull case) | Add 25% to position; re-rate to Overweight |
| Print <$6.00 OR NII guide weakens OR material CRE/provisioning acceleration (Q3 Bear case) | Exit 50-75% of position; downgrade to Underweight regardless of price action |
JPM's Q2 2026 earnings inflection (47% EPS growth) combined with oversold technicals, fortress balance sheet, and imminent Q3 catalyst creates a high-conviction BUY opportunity with 2:1 to 3:1 risk/reward.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 34.50 | bearish |
| MACD Line (12,26,9) | −5.70 | bearish |
| MACD Signal Line | −4.30 | bearish |
| MACD Histogram | −1.40 | bearish |
| 50 SMA | $351.82 | bearish |
| 200 SMA | $320.27 | bullish |
| 10 EMA | $336.74 | bearish |
| VWMA | $340.94 | bearish |
| Bollinger Middle Band (20 SMA) | $344.00 | neutral |
| Bollinger Lower Band | $326.29 | bearish |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: JPM closes above $351.82 on volume with RSI >55 and MACD histogram contracting
Then: Add 25% to position on pullback to 10 EMA
↩ rebuts: “Bear's focus on short-term moving averages (10 EMA, 50 SMA) rather than the structurally significant 200 SMA”
EV: +6% to 50 SMA at $351.82; +9% to prior high zone $361-$366 · concedes: One-day volume of 18.3M shares cited by bear as potential distribution (though bull argues 5-day average has been declining); P/B of 2.5x is elevated vs. sector peers; Q2 did include $4.39B special charge that inflated EPS
The bull case rests on a one-time inflated Q2 print, late-cycle macro dynamics that threaten peak NII and rising credit costs, and technicals showing accelerating bearish momentum with the 200 SMA likely to break rather than hold.
EV: -10% to -15% (if $320 breaks, next stop $285-$295) · concedes: Underlying Q2 NI ex-charge +11.8% YoY is fine growth; 200 SMA is indeed historically important support; Q2 was a 'great quarter' in absolute terms
→ vs conservative: Oversold RSI at 34.5 in a 47% earnings growth name is a gift, not a warning; technical breakdown already happened and is priced in
→ vs conservative: 1.6 to 1 reward-to-risk cited as insufficient ignores the fact that the 200 SMA at $320 has held every major pullback in the long-term uptrend
→ vs conservative: Late-cycle unemployment fears and slowing buyback pace are theoretical risks against proven $6.79B quarterly buyback power
→ vs neutral: Quiet institutional attention before earnings is the calm before the next leg, not a reason to stand down; ECM wallet share erosion to MS/GS is irrelevant to JPM's diversified franchise
→ vs neutral: HOLD with earnings imminent creates terrible expected value: modest drawdown on miss vs. ~5% upside on beat; accumulation into catalyst is mathematically superior
| Bollinger Upper Band | $361.71 | bullish |
| ATR (14) | $6.22 | neutral |
| Latest Close | $332.38 | bearish |
Support: 325.87 · 326.29 · 320.27 | Resistance: 336.74 · 340.94 · 344 · 351.82 · 361.71
JPM trades at $332.38, down approximately 9.2% from the August high of ~$366, with the stock below the 10-EMA ($336.74), 50-SMA ($351.82), VWMA ($340.94), and Bollinger middle band ($344.00), but above the 200-SMA ($320.27). The MACD bearish crossover occurred September 15, 2026, and momentum has continued accelerating downward; MACD worsened from −5.36 to −5.70 over consecutive sessions. The 200 SMA at $320.27 represents the critical long-term support and "line in the sand" for the strategic bull thesis, while the 50 SMA at $351.82 marks the medium-term breakdown level. Overall posture is defensive short-term but constructive long-term, with a HOLD recommendation pending price reclaim above $336.74 or break below $320.
Market Cap
$883.5B
Share Price (Implied)
$332.30
52-Week High
$366.50
52-Week Low
$279.10
50-Day MA
$352.24
200-Day MA
$321.77
P/E (TTM)
14.24x
Forward P/E
13.28x
PEG Ratio
1.54
Price/Book
2.50x
EPS (TTM)
$23.34
Forward EPS
$25.03
Dividend Yield
1.99%
Beta
1.015
Profit Margin
34.9%
Operating Margin
50.4%
Return on Equity (ROE)
17.8%
Return on Assets (ROA)
1.36%
Tax Rate
~23.1%
Total Revenue (TTM)
$186.3B
Net Income (TTM)
$63.6B
Revenue 4-Yr CAGR
+12.5%
EPS 4-Yr CAGR
+18.3%
Net Income 4-Yr CAGR
+14.7%
Q2 2026 Revenue
$52.85B
Q2 2026 Net Income
$21.16B
Q2 2026 Diluted EPS
$7.70
Q2 2026 Net Interest Income
$25.51B
Q2 2026 Special Charge
$4.39B
Q2 2026 Total Assets
$5,015.1B
Q2 2026 Net Loans
$1,516.3B
Q2 2026 Investments & Advances
$1,586.7B
Q2 2026 Trading Securities
$794.2B
Q2 2026 Held-to-Maturity
$268.5B
Q2 2026 Cash & Equivalents
$309.8B
Q2 2026 Goodwill + Intangibles
$64.3B
Q2 2026 Total Debt
$533.0B
Q2 2026 Net Debt
$223.1B
Q2 2026 Stockholders' Equity
$374.6B
Q2 2026 Tangible Book Value
$289.3B
Q2 2026 Common Stock Equity
$353.6B
2025 Dividends Paid
$16.6B
2025 Stock Buybacks
$34.6B
2025 Total Capital Return
$51.2B
Q2 2026 Cash Dividends
$4.34B
Q2 2026 Buybacks
$6.79B
Total Capitalization
$835.1B
Retained Earnings
$445B
Treasury Stock
$178.4B
2022 Total Revenue
$127.7B
2023 Total Revenue
$155.0B
2024 Total Revenue
$169.4B
2025 Total Revenue
$181.8B
2022 Net Income
$37.7B
2023 Net Income
$49.6B
2024 Net Income
$58.5B
2025 Net Income
$57.0B
2022 Diluted EPS
$12.09
2023 Diluted EPS
$16.23
2024 Diluted EPS
$19.75
2025 Diluted EPS
$20.02
2022 Total Assets
$3,665.7B
2025 Total Assets
$4,424.9B
Net Loans (2022)
$1.12T
Net Loans (2025)
$1.47T
2024 Restructuring Charges
$5.85B
Stockholders' Equity (2022)
$292B
Interest Income (Q2 2026)
$50.62B
Interest Expense (Q2 2026)
$25.11B
Net Debt Issuance (Q2 2026)
$7.6B
Strengths
Concerns
JPMorgan Chase is the highest-quality money-center bank globally, delivering Q2 2026 EPS of $7.70 (+47% YoY) on $52.85B revenue (+17.7% YoY), with best-in-class 17.8% ROE and 50.4% operating margin. The fortress balance sheet ($5T+ assets, $374.6B equity) supports consistent capital returns exceeding $50B annually. While the valuation premium (P/B 2.50x) and Q2 special charge warrant caution on aggressive new buying, JPM is best suited for long-term income-plus-growth positioning, with tactical entry points at pullbacks toward the 200-day MA ($321.77).
Macro: Fed policy held at 96% probability of zero cuts in 2026; US recession odds at 8%; unemployment stable at ≤5.0% (5% probability); soft landing path with late-cycle dynamics; gold rallying on weak September jobs; Nasdaq leading vs. Dow/small caps; FICC volatility environment constructive for trading revenue.